-
EP2536722
European procedure
Extract from the Register of European Patents
EP About this file: EP2536722
| EP2536722 - BICYCLIC COMPOUNDS AND THEIR USES AS DUAL C-SRC / JAK INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 20.02.2015 Database last updated on 12.07.2024 | Most recent event Tooltip | 20.02.2015 | No opposition filed within time limit | published on 25.03.2015 [2015/13] | Applicant(s) | For all designated states Debiopharm International SA Forum "après-demain" Chemin Messidor 5-7, CP 5911 1002 Lausanne / CH | For all designated states Aurigene Discovery Technologies Limited Electronic City Phase II, Hosur Road 39-40 (P) KIADB Ind Area Bangalore 560 100 / IN | [2014/28] |
| Former [2012/52] | For all designated states Debiopharm S.A. Forum "Après-Demain" Chemin Messidor 5-7 CP 5911 1002 Lausanne / CH | ||
| For all designated states Aurigene Discovery Technologies Limited Electronic City Phase II, Hosur Road 39-40 (P) KIADB Ind Area Bangalore 560 100 / IN | Inventor(s) | 01 /
MC ALLISTER, Andrès Rue Emile-Yung 8 CH-1205 Genève / CH | 02 /
MURONE, Maximilien Le Grand Chemin CH-1066 Epalinges / CH | 03 /
SENGUPTA, Saumitra 6/7 Central Park Kolkata 700032 / IN | 04 /
SHETTY, Shankar Jayaram 23 Rohini Apartment 9th Cross Wilson Garden Bangalore 560027 / IN | [2012/52] | Representative(s) | KATZAROV S.A. Geneva Business Center 12 Avenue des Morgines 1213 Petit-Lancy / CH | [N/P] |
| Former [2012/52] | KATZAROV S.A. European Patent Attorneys 19, rue des Epinettes 1227 Genève / CH | Application number, filing date | 11709484.7 | 17.02.2011 | WO2011IB50669 | Priority number, date | IN2010CHE0415 | 17.02.2010 Original published format: IN CH04152010 | [2012/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011101806 | Date: | 25.08.2011 | Language: | EN | [2011/34] | Type: | A1 Application with search report | No.: | EP2536722 | Date: | 26.12.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.08.2011 takes the place of the publication of the European patent application. | [2012/52] | Type: | B1 Patent specification | No.: | EP2536722 | Date: | 16.04.2014 | Language: | EN | [2014/16] | Search report(s) | International search report - published on: | EP | 25.08.2011 | Classification | IPC: | C07D471/04, A61K31/519, A61P35/00, A61P19/00, A61P37/00 | [2012/52] | CPC: |
C07D471/04 (EP,KR,US);
A61K31/519 (KR);
A61P19/00 (EP);
A61P19/08 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/00 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
A61P7/00 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2012/52] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | BICYCLISCHE VERBINDUNGEN UND IHRE VERWENDUNG ALS DUALE C-SRC / JAK-HEMMER | [2012/52] | English: | BICYCLIC COMPOUNDS AND THEIR USES AS DUAL C-SRC / JAK INHIBITORS | [2012/52] | French: | COMPOSÉS BICYCLIQUES ET UTILISATIONS ASSOCIÉES EN TANT QU'INHIBITEURS MIXTES DE C-SRC/JAK | [2012/52] | Entry into regional phase | 17.09.2012 | National basic fee paid | 17.09.2012 | Designation fee(s) paid | 17.09.2012 | Examination fee paid | Examination procedure | 17.09.2012 | Examination requested [2012/52] | 03.04.2013 | Amendment by applicant (claims and/or description) | 01.11.2013 | Communication of intention to grant the patent | 28.02.2014 | Fee for grant paid | 28.02.2014 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 01.11.2013 | Opposition(s) | 19.01.2015 | No opposition filed within time limit [2015/13] | Fees paid | Renewal fee | 21.02.2013 | Renewal fee patent year 03 | 20.02.2014 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO9961444 (WARNER LAMBERT CO [US], et al) [AD] 1-19 * tables 3a,7 * * claims 25,30 *; | [A]WO2005034869 (IRM LLC [US], et al) [A] 1-19 * page 35; example 7 * * claim 8 * * page 1 *; | [AD]WO2007088014 (HOFFMANN LA ROCHE [CH], et al) [AD] 1-19 * page 4 ** claims 1,8,9 * | by applicant | US3773919 | US4349472 | WO9961444 | US6713454 | US2005171328 | WO2007088014 | WO2008077062 | WO2008157208 | WO2009029998 | WO2009054941 | - HALPERN M. S.; ENGLAND J. M.; KOPEN G. C; CHRISTOU A. A.; TAYLOR R. L. JR., "Endogenous c-src as a Determinant of the Tumorigenicity of src Oncogenes", PROC NATL ACAD SD U S A, (1996), vol. 93, no. 2, doi:doi:10.1073/pnas.93.2.824, pages 824 - 827, XP002228324 DOI: http://dx.doi.org/10.1073/pnas.93.2.824 | - HAURA, E. B.; ZHENG, Z.; SONG, L.; CANTOR, A.; BEPLER, G., "Activated Epidermal Growth Factor Receptor-Stat-3 Signaling Promotes Tumor Survival In Vivo in Non-Small Cell Lung Cancer", CLIN. CANCER RES., (2005), vol. 11, no. 23, pages 8288 - 8294 | - JOHNSON, F. M.; SAIGAL, B.; TALPAZ, M.; DONATE, N. J., "Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non-small Cell Lung Cancer Cells", CLIN CANCER RES, (2005), vol. 11, doi:doi:10.1158/1078-0432.CCR-05-0757, pages 6924 - 6932, XP002558632 DOI: http://dx.doi.org/10.1158/1078-0432.CCR-05-0757 | - XI, S.; ZHANG, Q.; DYER, K. F.; LERNER, E. C; SMITHGALL, T. E.; GOODING, W. E.; KAMENS, J.; GRANDIS, J. R., "Src kinases Mediate STAT Growth Pathways in Squamous Cell Carcinoma of the Head and Neck", J BIOL CHEM, (2003), vol. 278, pages 31574 - 31583 | - G.R. PETTIT ET AL., ANTI-CANCER DRUG DESIGN, (2001), vol. 16, pages 185 - 193 | - D.L. MINOR ET AL., J. MED. CHEM., (1994), vol. 37, pages 4317 - 4328 | - M.J. MUNCHHOF ET AL., J. ORG. CHEM., (1995), vol. 60, pages 7086 - 7087 | - R.P. POLNIASZEK ET AL., TETRAHEDRON LETTERS, (1987), vol. 28, pages 4511 - 4514 | - N. UEMATSU ET AL., J. AM. CHEM. SOC., (1996), vol. 118, pages 4916 - 4917 | - G. MEUZELAAR ET AL., EUR. J. ORG. CHEM., (1999), pages 2315 - 2321 | - F.J. LEINWEBER, DRUG METAB. RES., (1987), vol. 18, page 379 | - Comprehensive Medicinal Chemistry, PERGAMON PRESS, (1990), vol. 5 | - TALAMONTI ET AL., J. CLIN. INVEST., (1993), vol. 91, page 53 | - LUTZ ET AL., BIOCHEM. BIOPHYS. RES., (1998), vol. 243, page 503 | - ROSEN ET AL., J. BIOL. CHEM., (1986), vol. 261, page 13754 | - BOLEN ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, page 2251 | - MASAKI ET AL., HEPATOLOGY, (1998), vol. 27, page 1257 | - BISCARDI ET AL., ADV. CANCER RES., (1999), vol. 76, page 61 | - LYNCH ET AL., LEUKEMIA, (1993), vol. 7, page 1416 | - SILVERMAN L.; SIGAL C. T.; RESH M. D., "Binding of pp[delta]Ov-src to Membranes: Evidence for Multiple Membrane Interactions", BIOCHEM CELL BIOL, (1992), vol. 70, no. 10- 11, pages 1187 - 92 | - BRICKELL, P. M, "The p60c-src Family of Protein-Tyrosine Kinases: Structure, Regulation, and Function", CRIT REV ONCOG., (1992), vol. 3, no. 4, pages 401 - 46 | - BROWN, M. T.; COOPER, J. A., "Regulations, Substrates, and Functions ofSrc", BIOCHIM. BIOPHYS. ACTA, (1996), vol. 1287, no. 2-3, pages 121 - 49 | - JOHNSON, F.M.; SAIGAL, B; TALPAZ, M.; DONATE, N.J., "Dasatin[iota]b (BMS- 354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non-Small Cell Lung Cancer Cells", CLIN. CANCER RES., (2005), vol. 11, pages 6924 - 6932 | - KISSELEVA T.; BHATTACHARYA S.; BRAUNSTEIN J.; SCHINDLER C. W., "Signaling Through the JAKJSTAT Pathway, Recent Advances and Future Challenges", GENE, (2002), vol. 285, doi:doi:10.1016/S0378-1119(02)00398-0, pages 1 - 24, XP004345658 DOI: http://dx.doi.org/10.1016/S0378-1119(02)00398-0 | - QUADROS, M. R.; PERUZZI, F.; KARI, C; RODECK, U., "Complex Regulation of Signal Transducers and Activators of Transcription 3 Activation in Normal and Malignant Keratinocytes", CANCER RES, (2004), vol. 64, pages 3934 - 3939 | - HEBENSTREIT D. ET AL., DRUG NEWS PERSPECT., (2005), vol. 18, no. 4, pages 243 - 249 | - KREBS, L. ET AL., STEM CELLS, (2001), vol. 19, pages 378 - 387 | - D W LEAMAN; S PISHARODY; T W FLICKINGER; M A COMMANE; J SCHLESSINGER; I M KERR; D E LEVY; G R STARK, "Roles of JAKs in Activation of STATs and Stimulation of c-fos Gene Expression by Epidermal Growth Factor", MOL CELL BIOL., (1996), vol. 16, no. 1, pages 369 - 375 | - HUA YU ET AL., NATURE REVIEWS, CANCER, (200911), vol. 9, page 798 |